VTD-PACE regimen: Difference between revisions

Jump to navigation Jump to search
Aparna Vuppala (talk | contribs)
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} ==Overview== {{PAGENAME}} refers to a regimen consisting of bortezomib (Velcade), thalidomide, dexamethasone, [..."
 
Aparna Vuppala (talk | contribs)
No edit summary
Line 6: Line 6:
{{PAGENAME}} refers to a regimen consisting of [[Bortezomib|bortezomib (Velcade)]], [[thalidomide]], [[dexamethasone]], [[cisplatin|Platinum (cisplatin)]], [[doxorubicin|Adriamycin (doxorubicin)]], [[cyclophosphamide]], [[etoposide]] used to treat [[multiple myeloma]]
{{PAGENAME}} refers to a regimen consisting of [[Bortezomib|bortezomib (Velcade)]], [[thalidomide]], [[dexamethasone]], [[cisplatin|Platinum (cisplatin)]], [[doxorubicin|Adriamycin (doxorubicin)]], [[cyclophosphamide]], [[etoposide]] used to treat [[multiple myeloma]]
.
.
==Regimen==
==Regimen==
{{chemo|V|Bortezomib (Velcade)}}
{{chemo|V|Bortezomib (Velcade)}}


{{chemo|T|Thalidomide}}


{{chemo|T|Thalidomide}}
{{chemo|D|Dexamethasone}}
{{chemo|D|Dexamethasone}}
{{chemo|P|Platinum (cisplatin)}}
{{chemo|P|Platinum (cisplatin)}}


Line 23: Line 22:


==Indications==
==Indications==
*[[Multiple myeloma]]
*[[Multiple myeloma]]


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Chemotherapy regimens]]
[[Category:Chemotherapy regimens]]

Revision as of 13:09, 30 March 2015

WikiDoc Resources for VTD-PACE regimen

Articles

Most recent articles on VTD-PACE regimen

Most cited articles on VTD-PACE regimen

Review articles on VTD-PACE regimen

Articles on VTD-PACE regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on VTD-PACE regimen

Images of VTD-PACE regimen

Photos of VTD-PACE regimen

Podcasts & MP3s on VTD-PACE regimen

Videos on VTD-PACE regimen

Evidence Based Medicine

Cochrane Collaboration on VTD-PACE regimen

Bandolier on VTD-PACE regimen

TRIP on VTD-PACE regimen

Clinical Trials

Ongoing Trials on VTD-PACE regimen at Clinical Trials.gov

Trial results on VTD-PACE regimen

Clinical Trials on VTD-PACE regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on VTD-PACE regimen

NICE Guidance on VTD-PACE regimen

NHS PRODIGY Guidance

FDA on VTD-PACE regimen

CDC on VTD-PACE regimen

Books

Books on VTD-PACE regimen

News

VTD-PACE regimen in the news

Be alerted to news on VTD-PACE regimen

News trends on VTD-PACE regimen

Commentary

Blogs on VTD-PACE regimen

Definitions

Definitions of VTD-PACE regimen

Patient Resources / Community

Patient resources on VTD-PACE regimen

Discussion groups on VTD-PACE regimen

Patient Handouts on VTD-PACE regimen

Directions to Hospitals Treating VTD-PACE regimen

Risk calculators and risk factors for VTD-PACE regimen

Healthcare Provider Resources

Symptoms of VTD-PACE regimen

Causes & Risk Factors for VTD-PACE regimen

Diagnostic studies for VTD-PACE regimen

Treatment of VTD-PACE regimen

Continuing Medical Education (CME)

CME Programs on VTD-PACE regimen

International

VTD-PACE regimen en Espanol

VTD-PACE regimen en Francais

Business

VTD-PACE regimen in the Marketplace

Patents on VTD-PACE regimen

Experimental / Informatics

List of terms related to VTD-PACE regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

VTD-PACE regimen refers to a regimen consisting of bortezomib (Velcade), thalidomide, dexamethasone, Platinum (cisplatin), Adriamycin (doxorubicin), cyclophosphamide, etoposide used to treat multiple myeloma .

Regimen

VBortezomib (Velcade)

TThalidomide

DDexamethasone

PPlatinum (cisplatin)

AAdriamycin (doxorubicin)

CCyclophosphamide

EEtoposide

Indications

References